Overview

Two Doses of the Intravenous Magnesium Sulfate Versus the Standard Single Dose ,With/ Without the Nebulized Budesonide For the Management of the Severe Asthma Exacerbation in the Emergency Room; A Randomized Controlled Trial.

Status:
Recruiting
Trial end date:
2022-10-01
Target enrollment:
0
Participant gender:
All
Summary
Many studies have investigated the efficacy and safety of Intravenous magnesium sulfate and inhaled steroids in addition to the standard treatment for patients with severe asthma attacks. In this 2x2 factorial design blinded randomized study, no interaction of hypothesized treatments is expected.Investigators hypothesize that two doses of intravenous magnesium sulfate,a high dose followed by a (lower) standard dose, will shorten the time to medical readiness for discharge compared to a single standard dose followed by placebo.The second hypothesis is that nebulized inhaled budesonide will be superior to placebo.
Phase:
Phase 3
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Hamad Medical Corporation
Treatments:
Budesonide
Magnesium Sulfate
Criteria
Inclusion Criteria:

1. Children 2-14 years of age.

2. Known to have bronchial asthma.

3. Presenting in severe asthma exacerbation

4. Asthma severity score 8 or higher according to PRAM asthma severity .

Exclusion Criteria:

1. Prematurity <34 weeks of gestation.

2. Critically ill children requiring immediate intubation or ICU admission.

3. Transfers from other institutions.

4. Adverse drug reaction or allergy to budesonide,salbutamol,ipratropium bromide,
prednisone, prednisolone, methylprednisolone, or magnesium sulfate.

5. History of neuromuscular disease, cardiac disease, renal disease, liver disease.

6. Underlying chronic lung disease.

7. Radiographic evidence of pneumonia or lung collapse .

8. Hemodynamic instability.

9. Instrumented airway or Tracheotomy.

10. Colostomy or ileostomy.

11. Malabsorption disorder.

12. Known vitamin D deficiency.

13. Receiving Milk of Magnesium for Constipation

14. Chronic diarrhea (duration for 2 weeks)

15. Diuretics use.

16. Immunodeficiency.